After surviving Ewing Sarcoma, 14-year-old Jude Baker used his Make-A-Wish not for a trip, but to help people experiencing ...

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussionsOS ...

Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in ...

Ipsen will withdraw Tazverik’s follicular lymphoma and epithelioid sarcoma indications as emerging data point to an elevated ...

Ipsen withdrew tazemetostat worldwide for follicular lymphoma and epithelioid sarcoma after new trial data suggested a less favorable safety profile than previously characterized. SYMPHONY-1 ...

Lilly Warren, whose family benefited in 2018, now volunteers with Inheritance of Hope at its Legacy Retreats for families ...

Jayden Bailey died after a nearly four-year battle with cancer. Here is his legacy and how he will be remembered.

Athletes in winter sport will have their moment in the spotlight at the Winter Paralympics in Italy, and two of Team USA’s competitors are from the D.C. area.

Ipsen telegraphed plans to acquire Epizyme and the FDA-approved Tazverik in June 2022, two years after the med’s clearance in the U.S. as both an epithelioid sarcoma and follicular lymphoma treatment.

Ipsen found cases of secondary malignancies in a confirmatory study of Tavzerik, a medicine it got in a purchase of Epizyme ...

The winter sports world is still buzzing from the recently concluded Olympic Games. Over the last few weeks, we watched Team ...